Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity-Reference-Cited by-同舟云学术

Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity

Published:2010-02-07 Issue:3 Volume:16 Page:339-345
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Flatz Lukas,Hegazy Ahmed N,Bergthaler Andreas,Verschoor Admar,Claus Christina,Fernandez Marylise,Gattinoni Luca,Johnson Susan,Kreppel Florian,Kochanek Stefan,Broek Maries van den,Radbruch Andreas,Lévy Frédéric,Lambert Paul-Henri,Siegrist Claire-Anne,Restifo Nicholas P,Löhning Max,Ochsenbein Adrian F,Nabel Gary J,Pinschewer Daniel D

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2104.pdf

Reference40 articles.

1. Harari, A. et al. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J. Exp. Med. 205, 63–77 (2008).

2. Peters, B.S. et al. Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity. Vaccine 25, 2120–2127 (2007).

3. Darrah, P.A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13, 843–850 (2007).

4. Kostense, S. et al. Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector. AIDS 18, 1213–1216 (2004).

5. Roberts, D.M. et al. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 441, 239–243 (2006).

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Viral Vector-Based Vaccines for Tuberculosis: A Patent Review (2010–2023);Vaccines;2024-08-02

2. Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaques;Journal of Virology;2024-07-23

3. Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates;Vaccines;2024-07-02

4. An attenuated lymphocytic choriomeningitis virus vector enhances tumor control in mice partly via IFN-I;Journal of Clinical Investigation;2024-06-11

5. Dendritic cell targeting in lymph nodes with engineered modular adapters improves HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21;2024-04-28